NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines

Кардиоваскулярная терапия и профилактика

V. I. Makolkin¹ 

[1] I.M. Sechenov First Moscow State Medical University;

关键词: arterial hypertension;    beta-blockers;    nebivolol;    metabolic disorders;   

DOI  :  

来源: DOAJ

【 摘 要 】

The paper discusses the position of beta-blockers, nebivolol in particular, in the Reappraisal 2009 of ESH/ESC Guidelines on arterial hypertension (AH) management. Nebivolol is not only highly selective towards beta-1 angiotensin II receptors, but also metabolically neutral, and therefore, could be used in AH patients with metabolic disorders.

【 授权许可】

Unknown